Alterations in the Gut Microbiome of Individuals With Tuberculosis of Different Disease States

被引:6
|
作者
Wang, Yue [1 ,2 ]
Deng, Yali [3 ]
Liu, Nianqiang [4 ]
Chen, Yanggui [5 ]
Jiang, Yuandong [1 ]
Teng, Zihao [1 ]
Ma, Zhi [1 ]
Chang, Yuxue [1 ]
Xiang, Yang [1 ]
机构
[1] Xinjiang Med Univ, Coll Publ Hlth, Dept Epidemiol & Biostat, Urumqi, Peoples R China
[2] Xinjiang Prod & Construct Corps, Ctr Dis Control & Prevent, Dept Women & Children & Community Hlth, Urumqi, Peoples R China
[3] Xinjiang Prod & Construct Corps, Ctr Dis Control & Prevent, Dept Dis Control & Prevent, Urumqi, Peoples R China
[4] Xinjiang Uygur Autonomous Region Ctr Dis Control, Ctr TB & Leprosy Control & Prevent, Urumqi, Peoples R China
[5] Dept TB Control & Prevent, Wulumuqi Ctr Dis Control & Prevent, Urumqi, Peoples R China
基金
中国国家自然科学基金;
关键词
tuberculosis; gut microbiota; 16S rRNA; Uyghur nationality; latent tuberculosis infection (LTBI); AKKERMANSIA-MUCINIPHILA; RISK; HOMEOSTASIS;
D O I
10.3389/fcimb.2022.836987
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
ObjectiveThere is evidence that the gut microbiota play a regulatory role in the occurrence and progression of tuberculosis. The purpose of the current study was to explore the alterations in gut microbiome under different tuberculosis disease stages in the Uyghur population, clarify the composition of microbial taxonomy, search for microbial biomarkers and provide innovative ideas for individual immune prevention and for control strategies. DesignA case-control study of Uyghur individuals was performed using 56 cases of pulmonary tuberculosis (PTB), 36 cases of latent tuberculosis infection (LTBI) and 50 healthy controls (HC), from which stool samples were collected for 16S rRNA gene sequencing. ResultsThe results showed that the alpha diversity indexes of the PTB group were lower than those of the other two groups (P <0.001), while only observed species were different between LTBI and HC (P <0.05). Beta diversity showed differences among the three groups (P = 0.001). At the genus level, the relative abundance of Bifidobacterium and Bacteroides increased, while Roseburia and Faecalibacterium decreased in the PTB group, when compared with the other two groups, but the changes between the LTBI and HC groups were not significant. The classifier in the test set showed that the ability of the combined genus to distinguish between each two groups was 81.73, 87.26, and 86.88%, respectively, and the validation efficiency was higher than that of a single screened genus. ConclusionThe gut microbiota of PTB patients was significantly disordered compared with LTBI and HC, while the changes of LTBI and HC were not significant. In the future, gut microbiota could be used as a non-invasive biomarker to assess disease activity.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Gut microbiome alterations in Alzheimer’s disease
    Nicholas M. Vogt
    Robert L. Kerby
    Kimberly A. Dill-McFarland
    Sandra J. Harding
    Andrew P. Merluzzi
    Sterling C. Johnson
    Cynthia M. Carlsson
    Sanjay Asthana
    Henrik Zetterberg
    Kaj Blennow
    Barbara B. Bendlin
    Federico E. Rey
    [J]. Scientific Reports, 7
  • [2] Gut microbiome alterations in Alzheimer's disease
    Vogt, Nicholas M.
    Kerby, Robert L.
    Dill-McFarland, Kimberly A.
    Harding, Sandra J.
    Merluzzi, Andrew P.
    Johnson, Sterling C.
    Carlsson, Cynthia M.
    Asthana, Sanjay
    Zetterberg, Henrik
    Blennow, Kaj
    Bendlin, Barbara B.
    Rey, Federico E.
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [3] Alterations of the gut microbiome in different stages of multiple sclerosis
    Takewaki, Daiki
    Sato, Wakiro
    Yamamura, Takashi
    [J]. NEUROLOGY, 2021, 96 (15)
  • [4] Gut microbiome alterations in preclinical Alzheimer's disease
    Jung, Joon Hyung
    Kim, Gihyeon
    Byun, Min Soo
    Lee, Jun Ho
    Yi, Dahyun
    Park, Hansoo
    Lee, Dong Young
    [J]. PLOS ONE, 2022, 17 (11):
  • [5] Alterations of the Human Gut Microbiome in Chronic Kidney Disease
    Ren, Zhigang
    Fan, Yajuan
    Li, Ang
    Shen, Quanquan
    Wu, Jian
    Ren, Lingyan
    Lu, Haifeng
    Ding, Suying
    Ren, Hongyan
    Liu, Chao
    Liu, Wenli
    Gao, Dan
    Wu, Zhongwen
    Guo, Shiyuan
    Wu, Ge
    Liu, Zhangsuo
    Yu, Zujiang
    Li, Lanjuan
    [J]. ADVANCED SCIENCE, 2020, 7 (20)
  • [6] Diagnostic model for predicting hyperuricemia based on alterations of the gut microbiome in individuals with different serum uric acid levels
    Liang, Meiting
    Liu, Jingkun
    Chen, Wujin
    He, Yi
    Kahaer, Mayina
    Li, Rui
    Tian, Tingting
    Liu, Yezhou
    Bai, Bing
    Cui, Yuena
    Yang, Shanshan
    Xiong, Wenjuan
    Ma, Yan
    Zhang, Bei
    Sun, Yuping
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [7] Alterations of Gut Microbiota in Patients With Intestinal Tuberculosis That Different From Crohn's Disease
    He, Cong
    Wang, Huan
    Yu, Chen
    Peng, Chao
    Shu, Xu
    Liao, Wangdi
    Zhu, Zhenhua
    [J]. FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2021, 9
  • [8] Study of gut microbiome alterations in plaque psoriasis patients compared to healthy individuals
    Polak, Karina
    Muszynski, Tomasz
    Fratczak, Aleksandra
    Meznerics, Fanni
    Banvolgyi, Andras
    Kiss, Norbert
    Miziolek, Bartosz
    Bergler-Czop, Beata
    [J]. POSTEPY DERMATOLOGII I ALERGOLOGII, 2024, 41 (04): : 378 - 387
  • [9] Alterations of the Gut Microbiome in Hypertension
    Yan, Qiulong
    Gu, Yifang
    Li, Xiangchun
    Yang, Wei
    Jia, Liqiu
    Chen, Changming
    Han, Xiuyan
    Huang, Yukun
    Zhao, Lizhe
    Li, Peng
    Fang, Zhiwei
    Zhou, Junpeng
    Guan, Xiuru
    Ding, Yanchun
    Wang, Shaopeng
    Khan, Muhammad
    Xin, Yi
    Li, Shenghui
    Ma, Yufang
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2017, 7
  • [10] Alterations of Gut Microbiome in Tibetan Patients With Coronary Heart Disease
    Liu, Fengyun
    Fan, Chao
    Zhang, Liangzhi
    Li, Yuan
    Hou, Haiwen
    Ma, Yan
    Fan, Jinhua
    Tan, Yueqin
    Wu, Tianyi
    Jia, Shangang
    Zhang, Yanming
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2020, 10